\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ ppd\ \(1\)\
\-\ increased\\ vascularity\\ on\\ cxr\ \(0\)\
\-\ chemotherapy\\ trial\ \(3\)\
\-\ admission\\ for\\ complications\ \(1\)\
\-\ rul\\ peribronchial\\ cuffing\\ with\\ rt\\ hilar\\ soft\\ tissue\\ mass\\.\\ multiple\\ tiny\\ nodules\\ distal\\ to\\ pulmonary\\ mass\\ and\\ cuffing\\.\ \(0\)\
\-\ lymphangitic\\ carcinomatosis\\ secondary\\ to\\ non\\-small\\ cell\\ lung\\ ca\ \(0\)\
\-\ tb\ \(176\)\
\-\ invasive\\ fungal\\ infection\ \(0\)\
\-\ sarcoid\ \(163\)\
\-\ lymphoma\ \(373\)\
\-\ 4\\ week\\ hx\\ increasing\\ hemoptysis\\ with\\ significant\\ smoking\\ hx\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cuffing\\:\\ 0\\.42773913068219227\ \(0\)\
\-\ hx\\:\\ 0\\.2914326672072715\ \(0\)\
\-\ peribronchial\\:\\ 0\\.20146616637682332\ \(0\)\
\-\ rul\\:\\ 0\\.19601570011780906\ \(0\)\
\-\ lymphangitic\\:\\ 0\\.1863351273027613\ \(0\)\
\-\ ppd\\:\\ 0\\.18200771523869627\ \(0\)\
\-\ rt\\:\\ 0\\.18007090519840524\ \(0\)\
\-\ trial\\:\\ 0\\.1782591404025535\ \(0\)\
\-\ tiny\\:\\ 0\\.17739529960019684\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.17343485499641415\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.16573069619384137\ \(0\)\
\-\ vascularity\\:\\ 0\\.16014843339715565\ \(0\)\
\-\ sarcoid\\:\\ 0\\.15018169489350283\ \(0\)\
\-\ smoking\\:\\ 0\\.1483094938827902\ \(0\)\
\-\ hilar\\:\\ 0\\.14683938779858502\ \(0\)\
\-\ invasive\\:\\ 0\\.14571633360363576\ \(0\)\
\-\ fungal\\:\\ 0\\.14334258694570007\ \(0\)\
\-\ tb\\:\\ 0\\.14259393962036793\ \(0\)\
\-\ ca\\:\\ 0\\.136626784954388\ \(0\)\
\-\ admission\\:\\ 0\\.13360937467971332\ \(0\)\
\-\ cxr\\:\\ 0\\.12810636749021986\ \(0\)\
\-\ nodules\\:\\ 0\\.12723807319202454\ \(0\)\
\-\ increasing\\:\\ 0\\.12612060781074302\ \(0\)\
\-\ complications\\:\\ 0\\.12264725685516799\ \(0\)\
\-\ mass\\:\\ 0\\.12233565008020318\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.11370742915260353\ \(0\)\
\-\ week\\:\\ 0\\.10770846203870853\ \(0\)\
\-\ negative\\:\\ 0\\.09913934256676445\ \(0\)\
\-\ pulmonary\\:\\ 0\\.09761051050017387\ \(0\)\
\-\ lung\\:\\ 0\\.0974128152397578\ \(0\)\
\-\ infection\\:\\ 0\\.09673164394626206\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09537113424506068\ \(0\)\
\-\ secondary\\:\\ 0\\.09491687496495499\ \(0\)\
\-\ distal\\:\\ 0\\.09304322043152681\ \(0\)\
\-\ significant\\:\\ 0\\.09245922232281782\ \(0\)\
\-\ cell\\:\\ 0\\.09160539136580181\ \(0\)\
\-\ increased\\:\\ 0\\.08659414359124022\ \(0\)\
\-\ soft\\:\\ 0\\.08525320487653554\ \(0\)\
\-\ tissue\\:\\ 0\\.08400393930910091\ \(0\)\
\-\ to\\:\\ 0\\.08006756449713212\ \(0\)\
\-\ multiple\\:\\ 0\\.0783261921992658\ \(0\)\
\-\ with\\:\\ 0\\.06271341323624775\ \(0\)\
\-\ for\\:\\ 0\\.04853610997035738\ \(0\)\
\-\ on\\:\\ 0\\.04836393763698572\ \(0\)\
\-\ and\\:\\ 0\\.03309022387606074\ \(0\)\
